Camber Launches Eletriptan Hydrobromide Tablets
Camber Pharmaceuticals continues to strengthen its range of treatment options with the introduction of Eletriptan Hydrobromide Tablets [EL-e-TRIP-tan].
Eletriptan Hydrobromide Tablets are indicated for the acute treatment of migraine, with or without aura in adults.
Eletriptan Hydrobromide Tablets are available in:
|
Strength |
Size |
| 20 mg |
6 (1 x 6) Unit-dose Tablets |
| 40 mg |
6 (1 x 6) Unit-dose Tablets |
To learn more about this product, visit: www.camberpharma.com/eletriptan-hydrobromide
Recent articles
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
- New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets






